Fundamentals of Oncology 2024: Hematopoiesis and Myelosuppression- Enduring Material, April 4, 2024-December 31, 2024
This course is designed to provide clinicians with basic oncology information and skills that would be applicable to any oncology patient population
Presenter Anna Vioral discloses no conflicts
Learning Objectives
1| Explain the hematopoiesis process
2| Differentiate types of myeloid and lymphoid cellular linages
3| Interpret lab values
4|Describe management of neutropenia
Accreditation
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditTM.
Available Credit
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Attendance